 Outlook Therapeutics NASDAQ:OTLK Inc revealed that BioLexis Private Limited, a strategic shareholder in the pre-commercial biopharmaceutical company, is being reorganized and has resulted in GMS Holdings emerging as its largest shareholder. The Singapore and Iselin, New Jersey-based biopharma company noted that the BioLexis reorganization, which does not entail any changes in the indirect ownership of Outlook Therapeutics NASDAQ:OTLK, provides GMS Holdings with increased flexibility to support Outlooks growth as its largest shareholder. 